Novel genetic aspects of congenital anomalies of kidney and urinary tract

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Weber, Stefanie ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; DIPEPTIDYL CARBOXYPEPTIDASE; EYA1 PROTEIN; FRAS1 PROTEIN; FREM2 PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; HMG BOX TRANSCRIPTION FACTOR; PROTEIN; PROTEIN RET; RENIN; SALL1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR SIX1; TRANSCRIPTION FACTOR SIX2; TRANSCRIPTION FACTOR SIX5; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG;

BLADDER MALFORMATION; BLADDER NECK STENOSIS; BRANCHIOOTORENAL SYNDROME; CHRM3 GENE; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 16P11.2; CHROMOSOME DUPLICATION; CLINICAL FEATURE; COLOBOMA; COMPARATIVE GENOMIC HYBRIDIZATION; DIABETES MELLITUS; DNA MICROARRAY; ECTOPIC KIDNEY; ECTOPIC URETER; FRASER SYNDROME; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC CODE; HEREDITY; HIRSCHSPRUNG DISEASE; HPSE2 GENE; HUMAN; HYPOTHESIS; KIDNEY ANOMALY; KIDNEY COLOBOMA SYNDROME; KIDNEY CYST; KIDNEY CYST AND DIABETES SYNDROME; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY HYPOPLASIA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE DYSGENESIS; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; ORGANOGENESIS; PELVIS URETER JUNCTION OBSTRUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PRUNE BELLY SYNDROME; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; TEASHIRT3 GENE; TOWNES BROCKS SYNDROME; URINARY TRACT MALFORMATION; UROFACIAL SYNDROME;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; KIDNEY; ORGANOGENESIS; SYNDROME; URINARY TRACT; UROGENITAL ABNORMALITIES;

EID: 84859104705     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834fdbd4     Document Type: Review

References (69)

1. Limwongse C, Clarren SK, Cassidy SB. Syndromes and malformations of the urinary tract. In Barratt TM, Avner ED, Harmon WE, editors. Pediatric nephrology. 4th ed. Baltimore: Lippincott Williams and Wilkins; 1998. pp. 415-426.
2. Piscione TD, Rosenblum ND. The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation 2002; 70:227-246. (Pubitemid 38230542)
3. Mackie GG, Stephens FD. Duplex kidneys: acorrelation of renal dysplasia with position of the ureteral orifice. J Urol 1975; 114:274-280.
4. Pope JC 4th, Brock JW 3rd, Adams MC, et al. How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT [review]. J Am Soc Nephrol 1999; 10:2018-2028. (Pubitemid 29402525)
5. Brodbeck S, Englert C. Genetic determination of nephrogenesis: the Pax/Eya/Six gene network [review]. Pediatr Nephrol 2004; 19:249-255. (Pubitemid 38313006)
6. Miyazaki Y, Oshima K, Fogo A, et al. Bone morphogenetic protein 4regulates the budding site and elongation of the mouse ureter. J Clin Invest 2000; 105:863-873. (Pubitemid 30203059)
7. Chevalier RL. Perinatal obstructive nephropathy [review]. Semin Perinatol 2004; 28:124-131. (Pubitemid 38590913)
8. Bingham C, Bulman MP, Ellard S, et al. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001; 68:219-224. (Pubitemid 32048377)
9. Ulinski T, Lescure S, Beaufils S, et al. Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. J Am Soc Nephrol 2006; 17:497-503.
10. Weber S, Moriniere V, Knüppel T, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol 2006; 17:2864-2870. (Pubitemid 44484676)
11. Adalat S, Woolf AS, Johnstone KA, et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 2009; 20:1123-1131.
12. Sainio K, Suvanto P, Davies J, et al. Glial-cell-line-derived neurotrophic factor isrequired for bud initiation from ureteric epithelium. Development 1997; 124:4077-4087. (Pubitemid 27484268)
13. Majumdar A, Vainio S, Kispert A, et al. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 2003; 130:3175-3185. (Pubitemid 36926955)
14. Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994; 367:377-378.
15. Skinner MA, Safford SD, Reeves JG, et al. Renal aplasia in humans is associated with RET mutations. Am J Hum Genet 2008; 82:344-351.
16. Pini Prato A, Musso M, Ceccherini I, et al. Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association. Medicine 2009; 88:83-90.
17. Sampson MG, Coughlin CR 2nd, Kaplan P, et al. Evidence for arecurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease. Am J Med Genet A 2010; 52A:2618-2262. Recent article underscoring the clinical and genetic association of Hirschprung disease and CAKUT.
18. Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:358-364.
19. Martinovic-Bouriel J, Benachi A, Bonnière M, et al. PAX2 mutations infetal renal hypodysplasia. Am J Med Genet A 2010; 152A:830-835. This recent study is the first one describing antenatal onset of renal coloboma syndrome.
20. Negrisolo S, Benetti E, Centi S, et al. PAX2 gene mutations in pediatric and young adult transplant recipients: kidney and urinary tract malformations without ocular anomalies. Clin Genet 2011; 80:581-585. In this very recent study, PAX2 mutations have been identified in adolescent renal transplant recipients who experienced end-stage renal failure due to nonsyndromic CAKUT. This underscores the importance of considering human gene mutations also in patients with nonsyndromic disease.
21. Abdelhak S, Kalatzis V, Heilig R, et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997; 15:157-164.
22. Ruf RG, Xu PX, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101:8090-8095. (Pubitemid 38698059)
23. Kochhar A, Orten DJ, Sorensen JL, et al. SIX1 mutation screening in247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum Mutat 2008; 29:565.
24. Hoskins BE, Cramer CH, Silvius D, et al. Transcription factor SIX5 ismutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80:800-804. (Pubitemid 46564416)
25. Chang EH, Menezes M, Meyer NC, et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004; 23:582-589. (Pubitemid 38720610)
26. Krug P, Morinière V, Marlin S, et al. Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Hum Mutat 2011; 32:183-190. This study describes comprehensive mutational analysis in one of the largest cohorts of BOR patients. The majority of mutations were identified in EYA1, very few in SIX and none in SIX5. These data support the relevance of EYA1 screening in families affected by BOR/BOS syndrome.
27. Gribouval O, Gonzales M, Neuhaus T, et al. Mutations in genes in the reninangiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005; 37:964-968. (Pubitemid 43086153)
28. Zivná M, Hulková H, Matignon M, et al. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet 2009; 85:204-213.
29. Beck BB, Trachtman H, Gitman M, et al. Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD. Am J Kidney Dis 2011; 58:821-825.
30. Weber S, Taylor JC, Winyard P, et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol 2008; 9:891-903.
31. Tabatabaeifar M, Schlingmann KP, Litwin M, et al. Functional analysis of bMP4 mutations identified in pediatric CAKUT patients. Pediatr Nephrol 2009; 24:2361-2368.
32. Jenkins D, Bitner-Glindzicz M, Malcolm S, et al. De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J Am Soc Nephrol 2005; 16:2141-2149. (Pubitemid 41716446)
33. Schönfelder EM, Knüppel T, Tasic V, et al. Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans. Am J Kidney Dis 2006; 47:1004-1012. (Pubitemid 43767324)
34. Saisawat P, Tasic V, Vega-Warner V, et al. Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis. Kidney Int 2011. doi: 10.1038/ki.2011.315. [Epub ahead of print] This study describes the successful application of novel sequencing techniques (e.g. exon capture and next generation sequencing) in patients affected by CAKUT. Mutations in different renal developmental genes have been identified, among these FRAS1 and FREM2.
35. Kohlhase J, Wischermann A, Reichenbach H, et al. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat Genet 1998; 18:81-83. (Pubitemid 28027886)
36. Botzenhart EM, Bartalini G, Blair E, et al. Townes-Brocks syndrome: twenty novel SALL1 mutations in sporadic and familial cases and refinement of the SALL1 hot spot region. Hum Mutat 2007; 28:204-205.
37. Feather SA, Malcolm S, Woolf AS, et al. Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet 2000; 66:1420-1425. (Pubitemid 30468798)
38. Lu W, van Eerde AM, Fan X, et al. Disruption of rOBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux. Am J Hum Genet 2007; 80:616-632. (Pubitemid 46564400)
39. Jenkins D, Caubit X, Dimovski A, et al. Analysis of tSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction. Nephrol Dial Transplant 2010; 25:54-60.
40. Gimelli S, Caridi G, Beri S, et al. Mutations in SOX17 are associated with congenital anomalies of the kidney and the urinary tract. Hum Mutat 2010; 31:1352-1359. Recent study that identified a new gene, SOX17, involved in CAKUT associated with VUR.
41. Farrugia M-K, Woolf AS. Congenital urinary bladder outlet obstruction. Fetal Matern Med Rev 2010; 21:55-73.
42. Daly SB, Urquhart JE, Hilton E, et al. Mutations in HPSE2 cause urofacial syndrome. Am J Hum Genet 2010; 86:963-969. Important study reporting for the first time a monogenetic basis in patients affected by bladder dysfunction associated with urofacial/Ochoa syndrome. Apart from expression of HPSE2 in the central nervous system it is also expressed in smooth muscle of the bladder, consistent with a role in renal tract morphology and function.
43. Pang J, Zhang S, Yang P, et al. Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome. Am J Hum Genet 2010; 86:957-962.
44. Mahmood S, Beetz C, Tahir M, et al. First HPSE2 missense mutation in urofacial syndrome. Clin Genet 2012; 81:88-92.
45. Al Badr W, Al Bader S, Otto E, et al. Exome capture and massively parallel sequencing identifies a novel HPSE2 mutation in a Saudi Arabian child with Ochoa (urofacial) syndrome. J Pediatr Urol 2011; 7:569-573.
46. Weber S, Thiele H, Mir S, et al. Muscarinic acetylcholine receptor M3mutation causes urinary bladder disease and a prune-belly-like syndrome. Am J Hum Genet 2011; 89:668-674. Most recent study applying novel sequencing techniques to detect the genetic cause in a family affected by bladder dysfunction and PBS, a heterogeneous condition frequently associated with severe impairment of kidney function. Here, for the first time, a genetic defect in a human muscarinic acetylchline receptor has been identified in the receptor subtype M3, the major receptor involved in urinary bladder contraction during micturition.
47. Matsui M, Motomura D, Karasawa H, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A 2000; 97:9579-9584. (Pubitemid 30650818)
48. Weber S, Landwehr C, Renkert M, et al. Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant 2010; 26:136-143.
49. Becknell B, Pais P, Onimoe G, Rangarajan H, et al. Hepatoblastoma and prune belly syndrome: a potential association. Pediatr Nephrol 2011; 26:1269-1273.
50. Ben Saddik MA, Sejiny SAQ, Ndoye M, Gil-diez-de-Medina S, et al. Flexible ureteroscopy in the treatment of kidney stone between 2 and 3 cm [French]. Prog Urol 2011; 21:327-332.
51. Berry R, Harewood L, Pei LM, Fisher M, et al. Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla. Hum Mol Genet 2011; 20:917-926.
52. Chen GM, Chen SW, Xia D, Li J, et al. Sarcomatoid carcinoma of the renal pelvis in duplex kidney. Chin Med J 2011; 124:2074-2076.
53. Daly SB, Urquhart JE, Hilton E, et al. Mutations in HPSE2 cause urofacial syndrome. Am J Hum Genet 2010; 86:963-969. [42]
54. Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, et al. Candida Urinary Tract Infection: Pathogenesis. Clin Infect Dis 2011; 52:S437-S451.
55. Gimelli S, Caridi G, Beri S, et al. Mutations in SOX17 are associated with congenital anomalies of the kidney and the urinary tract. Hum Mutat 2010; 31:1352-1359. [40]
56. Guo QS, Tripathi P, Poyo E,Wang YQ, et al. Cell Death Serves as a Single Etiological Cause of a Wide Spectrum of Congenital Urinary Tract Defects. J Urol 2011; 185:2320-2328.
57. Jones RA, Grattan-Smith JD, Little S. Pediatric Magnetic Resonance Urography [Review]. J Magn Reson Imaging 2011; 33:510-526.
58. Kajbafzadeh AM, Javan-Farazmand N, Motamedi A, Monajemzadeh M, et al. The optimal dose of adriamycin to create a viable rat model potentially applicable to congenital obstructive uropathy. J Pediatr Surg 2011; 46:1544-1549.
59. Krug P, Morinière V, Marlin S, et al. Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Hum Mutat 2011; 32:183-190. [26]
60. Martinovic-Bouriel J, Benachi A, Bonnière M, et al. PAX2 mutations infetal renal hypodysplasia. Am J Med Genet A 2010; 152A:830-835. [19]
61. Negrisolo S, Benetti E, Centi S, et al. PAX2 gene mutations in pediatric and young adult transplant recipients: kidney and urinary tract malformations without ocular anomalies. Clin Genet 2011; 80:581-585. [20]
62. Reginensi A, Clarkson M, Neirijnck Y, Lu BS, et al. SOX9 controls epithelial branching by activating RET effector genes during kidney development. Hum Mol Genet 2011; 20:1143-1153.
63. Rogenhofer S, Muller SC. Hydronephrosis [German]. Urologe 2011:545-.
64. Saisawat P, Tasic V, Vega-Warner V, et al. Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis. Kidney Int 2011. doi: 10.1038/ki.2011.315. [Epub ahead of print] [34]
65. Sampson MG, Coughlin CR, 2nd, Kaplan P, et al. Evidence for arecurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease. Am J Med Genet A 2010; 52A:2618-2262. [17]
66. Wang B, Zhou JH, Jin HM. Torsion of arudimentary uterine horn at 22 weeks of gestation. J Obstet Gynaecol Res 2011; 37:919-920.
67. Weber S, Landwehr C, Renkert M, Hoischen A, et al. Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol Dial Transplant 2011; 26:136-143.
68. Weber S, Thiele H, Mir S, et al. Muscarinic acetylcholine receptor M3mutation causes urinary bladder disease and a prune-belly-like syndrome. Am J Hum Genet 2011; 89:668-674. [46]
69. Yosypiv IV. Renin-angiotensin system in ureteric bud branching morphogenesis: insights into the mechanisms [Review]. Pediatr Nephrol 2011; 26:1499-1512.